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This study was aimed at establishing the baseline values of CD4 and CD8 absolute counts among healthy pregnant women 
in Ekpoma, Edo State, Nigeria. Ninety (90) apparently healthy pregnant women between the age group of 18-39 years and 
thirty (30) non- pregnant women (control) were used as study subjects. The pregnant subjects were divided into three 
groups, depending on the trimester of pregnancy. CD4 and CD8 absolute counts were determined using flow cytometry. 
An automated blood analyzer was used to determine the leucocyte counts. The mean WBC (total) count (x10
3
/μl) of the 
pregnant women was 7.71±1.76 against 4.97 ± 0.82 of the control subjects. Statistical comparison showed a statistical 
significance changes in the mean CD4 counts between the test and control subjects but no statistical significant difference 
in the total WBC and absolute CD8 counts of both groups (P>0.05). In contrast, the CD4 absolute count showed a 
statistical significant difference when compared with the mean values of the control subjects. In conclusion, pregnancy 
significantly increased the mean values of WBC count but significantly decreased CD4+ cell count when compared to non-
pregnant controls while the mean CD8+ cell count did not show any difference in the subjects studied. 
 




The “CD” or Cluster of differentiation is a protein expressed on the surface of the cells of the haematopoietic system. The 
expression of these proteins is used in lymphocyte nomenclature (Wingood, 2003). Over three hundred (300) “CD” 
molecules have been reported so far.CD for humans is numbered up to three hundred and seventy one (371) ( as of 21 
April 2016) ( Zola et al.,2007; HCDM,2016 ). These proteins are often associated with the specific function of the cells. It 
is a protocol used for the identification and investigation of cell surface molecules providing targets for 
immunophenotyping of cells (Chan et al.,1988). Cells with different function express different CD molecules. For 
example, the CD3+ cells are total T-lymphocytes, CD4+ are T-helper cells and CD8+ cells are cytotoxic T-lymphocytes. 
 
The CD4 T-lymphocyte occupy the central position in regulating immune functions. The CD4 T-lymphocytes also known 
as T-helper cells, are co-ordinators of the body’s immune response e.g. providing help to B-cells in the production of 
antibody, as well as in augmenting cellular immune response to antigens (Kapiga et al., 2009). 
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CD8 is a transmembrane glycoprotein that serves as co-receptors for the T cell receptor (TCR). CD8 T cells are an 
essential component of the adaptive immune system .Cytotoxic T cells (also known as TC, killer T cells, or cytotoxic T-
lymphocytes ( CTL) are a subgroup of T cells that induce the death of cells that are infected with viruses ( and other 
pathogens), or are otherwise damaged or dysfunctional ( Janeway et al.,2001).  They display potent cytolytic activity  
against pathogen – infected host cells but are also involved during pregnancy when they aid in foetal implantation and 
prevention of foetal abortion. Activated CD8 T cells are expressed as part of the host regulatory response to control T-cell 
activity (Scaife et al., 2006). 
 
Pregnancy is a unique state where the physiology of a woman is greatly altered to accommodate the newly developing 
“organ” the foetus (Loh et al., 2004). Pregnancy leads to many functional (physiological) and structural (anatomical) 
changes in the body. They occur due to the needs of the developing baby, placenta and the uterus and the increasing levels 
of pregnancy hormones especially progesterone and estrogen (Murray and Mcjibbey, 2010). Pregnant women are not 
immune suppressed in the classic sense, but physiological changes induce a state of relative immune-suppression in 
cellular immune of response. Pregnancy induces a unique challenge for the maternal immune system, which must tolerate 
the presence of a semiallogeneic foetus and still maintain a strong immune response against invading pathogens (Ogawa, 
2003). 
 
In individuals with HIV infections, assessment of CD4 and CD8 cell counts is fairly common and they are routine indices 
for the evaluation of immune status and decision to initiate anti-retroviral drug  therapy, ART (Gange et al., 2003). Also 
with the advent of anti retroviral therapy (ART) and other interventions to improve maternal and child health, pregnant 
women and infants are the focus of many health programs, including prevention of mother-to-child transmission (PMTCT). 
Recruitment of pregnant women into clinical trials and overall clinical management require accurate laboratory reference 
intervals for correct interpretation and decision making (Miri-Dashe et al., 2014). 
 
Data on normal ranges of CD4, CD8 and leucocyte counts in Ekpoma especially amongst pregnant women are generally 
lacking. It would therefore be needful to establish appropriate normal reference values for T cell subsets among the 
obstetric population of Ekpoma, Nigeria. 
 
MATERIALS AND METHODS 
 
Study Area: This study was carried out in Ekpoma, the administrative headquarters of Esan West Local Government Area 












E of the 
Greenwich Meridian. It is the fourth largest town in Edo State and has an area of 502km
2
 and a population of 89,628 in 
1991 and 127,718 in 2006 majority of which are civil servants, traders, business men/women, farmers, teachers, lecturers 
and students by occupation. Ekpoma since its designation as headquarters and as the host of the state – owned university 
(Ambrose Alli University), has grown into an urban centre (Aziegbe, 2006). 
 
Study Population: This study was a descriptive cross-sectional study conducted in Ekpoma at the maternity clinics of 
Osemudiamen Specialist Hospital and Esan West Local Government Area between January and June, 2017 on ninety (90) 
apparently healthy pregnant subjects. The subjects were aged between 18-39 years of age while thirty non-pregnant women 
served as control subjects. 
 
Study Design: This study involved apparently healthy pregnant subjects. Only HIV 1/2, Hepatitis (B and C) viruses and 
VDRL seronegative subjects were recruited into this study. The participants were selected by simple random sampling. 
Each consenting participant was asked to fill a questionnaire and administered a consent form A and B to read and sign 
respectively. All participants were screened in or out based on both the inclusion and exclusion criteria captured in the 
questionnaire. 
 
Inclusion Criteria: Only apparently healthy pregnant women between 18 and 39 years and seronegative for HIV 1/2, 
Hepatitis (B and C) viruses and VDRL were recruited into the study. 
 
Exclusion Criteria: Women who were breast-feeding, HIV-positive, menstruating or on any form of oral contraceptive 
and antiretroviral therapy at the time of study were excluded. 
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Blood Collection: Within the time frame of 9.00am-12.00noon, four (4) milliliters of blood was collected through 
venepuncture from the antecubital vein into ethylene diamine tetraacetic acid (EDTA) tubes in accordance with biosafety 





the laboratory and were analyzed within six hours of sample collection. 
 
Specimen Analysis (A): HIV sero-reactivity was determined according to the national algorithm II. Serial testing was 
carried out using Determine HIV – 1/2 test Kit in the first instance and Unigold HIV – 1/2 test was only used when 
Determine HIV 1/2 test was sero-reactive and discordant results resolved with the third kit,Stat Pak (tie-breaker). All the 
three test kits (Determine, Alere Medical Co. Ltd, Japan; Unigold, Trinity Biotech Plc, Ireland; and Stat Pak, Chembio 
Diagnostics systems, Inc., USA) were used according to the manufacturers’ instructions. Participants were categorized as 
HIV non-reactive when they did not react with Determine HIV –1/2 rapid test kit. 
 
Specimen Analysis (B): The CD4 and CD8 counts were determined using Partec cyflow machine (SysmexPartec GmbH, 
Görlitz, Germany) according to the manufacturer’s instructions. The cyflow counter is based on the simultaneous 
measurement of multiple physical characteristics of CD4 and CD8 T lymphocytes (at different times) in a single file as it 
flows through a light source usually a laser beam. The counter separated the CD4+ or CD8+ T cells from the monocytes 
CD4 or CD8 bearing cells and noise using a gating system. Leucocyte counts (total and differential leucocyte counts) were 
determined with Sysmex KX-21-N Haematology auto analyzer (Sysmex Corporation, Japan).  
 
Ethical Approval: Approval for the study was obtained from the University Ethics Committee in accordance with the 
code of ethics for biomedical research involving human subjects. Written informed consent of each participant was 
obtained. However, illiterate participants had their consent forms read and interpreted to them in their native languages by 
an interpreter. 
 
Statistical Analysis: The data obtained were expressed as means ± standard errors of means (SEM). The medians were 




 percentiles. Statistical significance was determined using 
the analysis of variance (ANOVA) or the Student’s t-test as appropriate. P<0.05 was considered significant. All statistical 




Table 1 summarizes the socio-demographic characteristics of pregnant and non-pregnant women in the study area. The 
mean age of the subjects (pregnant women) was 31.70 ± 5.55 years compared to control subjects (28.70 ± 6.60 years). 
According to gestational age, the mean age in weeks were 10.30 ± 0.72, 20.10 ± 1.10 and 30.70 ± 0.70 for the first, second 
and third trimesters respectively. Based on occupation, most of the pregnant subjects recruited for the study were civil 
servants while those who did not have any specific occupation (ie others) were the least. 
 
Table 2 revealed the WBC (total), CD4 and CD8 counts of the pregnant and control subjects. The mean WBC (total) count 
(x10
3
/μl) of the pregnant women was 7.71 ± 1.76 against 4.97 ± 0.82 of the control subjects. This comparison showed a 
statistical significant increase (P<0.05) between the pregnant women and the control subjects. The mean CD4 absolute 
counts of pregnant women against those of the control subjects were 614.49 ± 266.87 cells/μl and 935.40 ± 306.56 cells/μl 
respectively. This showed a statistically significant decrease (P < 0.05) in thse CD4 count of pregnant women compared to 
control subjects. The mean CD8 absolute counts of pregnant women and control subjects were 411.31 ± 161.76 cells/μl and 
380.87 ± 126.50 cells/μl respectively. There was no statistical significant difference in the mean CD8 absolute counts of 
both groups (P > 0.05). 
 
Table 3 depicted the WBC (total), CD4 and CD8 counts of pregnant women with respect to trimesters. There was no 
significant difference (P > 0.05) in the WBC (total) in the first trimester, second trimester and third trimester with 
respective mean values of 7.02 ± 1.71, 7.14 ± 2.15 and 7.33 ± 1.37. The mean CD4 absolute counts of pregnant women for 
the first trimester, second trimester and third trimester were 578.53 ± 291.43 cells/μl, 563.70 ± 246.05 cells/μl and 701.23 ± 
247.62 cells/μl respectively. This showed a statistical significant difference when compared with the mean values of the 
control subjects. For CD8 count, the results presented in mean ± standard deviation showed a non-significant difference (P 
> 0.05) in the three trimesters when compared with non-pregnant women. 
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TABLE 1: SOCIO-DEMOGRAPHIC PROFILE OF APPARENTLY HEALTHY PREGNANT SUBJECTS AND 
CONTROL 
 




Age (mean ± SD in years) 31.70 ± 5.55 28.70 ±6.60 
   
Gestation age (Mean ± SD  








Second trimester 20.10 ± 1.10 - 
Third trimester 30.70 ± 0.70 - 
   
Occupation   
Civil servants 35 (38.9) 16 (53.3) 
Business women 25 (27.8) 9 (30.0) 
Self employed 18 (20.0) 5 (16.7) 
Others 12 (13.3) - 
Total 90 (100.0) 30 (100.0) 
 
 
TABLE 2: THE WBC (TOTAL), CD4 AND CD8 COUNTS OF THE STUDY SUBJECTS 
 
Parameter Control subjects Mean ± SD 
N=30 
Pregnant subjects Mean ± SD 
N=90 
T-value P-value 
WBC 4.97 ± 0.82 7.17 ± 1.76 6.602 0.000(S) 
CD4 935.40 ± 306.56 614.49 ± 266.87 5.492 0.000(S) 
CD8 380.87 ±126.50 411.31 ± 161.76 0.939 0.350(NS) 
 





































 14.548 0.000 
CD4 935.40±306.56
a















 0.441 0.724 
Values in rows with different superscripts are significantly different at p < 0.05 
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CD4 and CD8 counts are widely used prognostic markers to assess the degree of immune impairment in HIV seropositive 
individuals and to monitor antiretroviral therapy (ART). Pregnancy is considered as a physiologically 
immunocompromised state, hence alterations in T lymphocyte subsets may occur during pregnancy. There is need to 
establish baseline values of these counts, especially in healthy pregnant women (Danyama et al., 2003). 
 
In this study, the mean CD4 absolute count obtained was 614.49 cells/μl. The mean CD4 absolute count recorded in 
Ekpoma is lower than those found by previous authors. Tanjong et al (2012) reported a mean value of 851 cells/μl among 
pregnant subjects residing in Buea, Cameroon. In Nigeria Aina et al (2005) and Akinbami et al (2014) both reported 
similar mean values of 771 cells/μl and 771.9 cells/μl among seronegative pregnant subjects they studied in Ilorin and 
Lagos respectively. In Pune, India, Dayamaet al (2003) reported a mean value of  764 cells/μl while Chama et al. (2009) 
found a mean value of 751.41 cells/μl in Maiduguri, Borno State, Nigeria. Makrydimas et al (1994) also reported increased 
CD4 count during pregnancy in British women. These higher counts may be due to physiological leucocytosis due to 
repeated infections. 
 
In contrast, our mean CD4 absolute count value is higher than the mean value of 578.3 cells/μl reported in another part of 
Nigeria by Ekwempuet al. (2012). In a recent study also among HIV – uninfected pregnant women in Malawi, Mandala et 
al (2017) reported a mean value of 468 cells/μl. Towers et al. (2010) also reported that the mean absolute lymphocyte cell 
count, lymphocyte percentage and absolute CD4 cell count are significantly lower in pregnancy. Bisalkumi et al. (1992) 
also reported that absolute numbers of CD4+ were reduced during pregnancy in African women. Burns et al. (1996) also 
reported a reduced mean value for American women. It has been observed that pregnancy alone, in the absence of HIV 
infection, was associated with a reduction in lymphocytes and T cell numbers across all subsets and with a neutrophilia 
consistent with what has been observed in some studies (Pitkin and Witte, 1979; Valdimarsson et al, 1983; Ballock and 
Cauchi, 1993; Kuhnert et al., 1998; De Santis, 2011) but not in others (Tallon et al., 1984; Maclean et al, 1992; Watanabe 
et al., 1997). The lack of consistency in changes in total lymphocytes and subsets in pregnancy found in different studies 
could be because these cell subsets have previously been shown to be affected by other factors such as location  and ethnic 
group (Mandala et al., 2010). Ekwempu et al (2012) attributed the other factors to be stress or decreased immunity. There 
is some evidence to suggest that in HIV – uninfected women, pregnancy per se is associated with suppression of humoural 
and cellular immunity (Kumar et al., 1984; Weinberg, 1984; Biedermann et al., 1995). 
 






) were 578.53±291.43 cells/μl, 
563.70±246.05 cells/μl and 701.31±247.62 cells/μl respectively. The CD4 mean values and gestational age were not 
statistically significant (P > 0.05). This finding is in consonance with the previous reports of Akinbami et al (2014) and 
Ekuempu et al (2012) who both found a statistically insignificant association between CD4 and gestational age. 
Temmerson et al (1995) also reported no association between duration of pregnancy and immune markers and the pattern 
of immunological markers described for HIV-infected women were similar to those of uninfected controls. Contrary to our 
finding, Okeke et al (2016) reported that CD4 of non-HIV infected pregnant women increased from second trimester 
through third trimester and was found to have a significant increase. Okeke et al (2016) suggested that this indicated that 
pregnancy alone can influence increase in CD4 cell through 3
rd
 trimester and attributed the increase might be a result of 
physiological endocrine changes in pregnancy.  
 
Lieve et al (2007) noted that pregnancy  hormones slowdown the decline in the rate of CD4 cell count though not 
sustainable. It was observed that the changes in the CD4 cell count which is a subset of total leucocyte count (TLC) does 
not significantly reflect in total lymphocyte count of the pregnant women. However, Chama et al (2009) reported that the 
mean CD4 count was higher in the 1
st
 trimester than in later parts of pregnancy while Towers et al (2010) observed a 
significantly lower CD4 cell count during pregnancy and stated that the progression through pregnancy was u-shaped. 
Anglaret et al (1994) attributed the higher mean CD4 counts in some trimesters to be due to physiological leucocytosis due 
to infections. 
 
The mean CD8 absolute of pregnant women in Ekpoma was 411.31±161.76 cells/μl. This finding is at variance with the 
previous report of Dayama et al (2003) who found the mean values of 547±56.49 cells/μl. Mwinga et al (2009) also 
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reported mean values of 513.5 cells/μl and 506.8 cells/μl in the second and third trimesters respectively. It is noteworthy to 
mention here that Danyama et al (2003) recruited participants in third trimester only whereas Mwinga et al. (2009) 
enrolled into their study only second and third trimesters of HIV-uninfected pregnant women. Therefore, the nature of 
these two studies might have skewed the statistics in comparison to our study that determined the mean of all our subjects 
in the three trimesters. Nevertheless, the mean CD8 values obtained by these previous authors in these two trimesters were 
higher than the mean values we obtained in our study. According to Anglaret et al. (1997), the higher counts found in these 
subjects might also be due to physiological leucocytosis due to repeated infections. In contrast, Mandala et al (2017) found 
a mean CD8 value of 270 cells/μl among the 54 HIV-uninfected pregnant women they studied. Towers et al (2010) also 
reported a mean absolute CD8+ cell count that was not significantly different and therefore appears to be unaffected during 
pregnancy. Other authors (Bisalinkumi et al. (1992) and Makrydimas et al. (1994)) both reported decreased CD8 counts 
during pregnancy in African and British women respectively. Therefore, regional diversity in the T-lymphocyte subset 
count is evident. In addition to the regional changes, variations could also be due to use of different equipment and 
techniques in different studies and could have given rise to procedural and instrumental errors. 
 






) were 418.73 cells/μl, 419.43 
cells/μl and 395.77 cells/μl respectively. The statistical analysis revealed that there was no significant association between 
CD8 and gestational age in our study subjects. Our finding is in line with the report of Towers et al (2010) who also found 
that the mean absolute CD8+ cell count is not significantly different. In contrast, our finding disagreed with the previous 
report of Dayama et al. (2003) who found mean values of 547.00 cells/μl among the subjects they studied. Danyama et al. 
(2003) recruited only third trimester pregnant subjects. In addition, Mwinga et al. (2009) reported mean values of 513.5 
cells/μl and 506.8 cells/μl in the second and third trimesters of the subjects they studied. The same reasons earlier 
mentioned might also be responsible for this. However, Mandala et al (2017) reported a lower mean value of 270 cells/μl 
among the subjects they studied. Bisalinkumi et al (1992) and Makrydimas et al (1994) also found decreased CD8 counts 
during pregnancy. Diminished immunoreactivity during pregnancy is important in preventing rejection of the foetus, which 
from an immunological point of view is foreign tissue. 
 
The mean WBC total count (x10
3
/μl) of pregnant women in Ekpoma was 7.71 against 4.97 of the control subjects. This 
showed a statistically significant increase (P < 0.05) in pregnant women compared to control subjects. Our finding is in 
tandem with the report of Towers et al. (2010) who observed an elevated mean white blood cell (WBC) count above the 
non-pregnant state and this parameter increased throughout the pregnancy to and including parturition. Another study 
reported that althsough changes in leucocyte counts during pregnancy in African women were similar to those reported in 
Caucasian women, the total WBC counts were lower in the African women (Fleming and Harrison, 1985). In contrast, our 
WBC count mean value was lower than the mean value of 12.3 (x10
3
/μl) reported by Mandala et al. (2017) among 
pregnant Malawian women. The WBC count for normal male and female adults is 4,500 – 11,000/μl (range is estimate of 
95% confidence limits) (Geaghan, 2009). White blood cell count is increased in pregnancy with the lower limit of the 
reference range being typically 6,000/cumm (Chandra et al., 2012). Leucocytosis occurring during pregnancy is due to 
physiologic stress induced by the pregnant state (Fleming, 1975). Neutrophils are the major type of leucocytes on 
differential counts (Gatti et al., 1994; Konijnenberg et al., 1997). This is likely due to impaired neutrophilic apoptosis in 
pregnancy (Gatti et al., 1994). 
 
There was no significant difference (P > 0.05) in the WBC (total) count in the first trimester, second trimester and third 
trimester with respective mean values of 7.02, 7.14 and 7.33. This is close to the report of Mwinga et al (2009) who found 
mean values of 6.9 and 6.7 in the second and third trimesters respectively. Statistical comparison between the two mean 
values of the test and control subjects did not show any statistical significant difference also. Our finding contradicted the 
previous report of Mandala et al. (2017) who found a mean value of 5.8 among 54 pregnant HIV-uninfected women. 
Milhorat et al (1942) observed that this may have been due to the significant increase in neutrophil count during 
pregnancy, possibly related to stress response, redistribution of WBC during the marginal and circulating pools or pain, 
nausea, vomiting and anxiety in the absence of infection. On the contrary, Okeke et al (2016) reported lower mean WBC 
total count (x10
3




 trimesters respectively among HIV-uninfected pregnant 
women in another part of Nigeria. The reason for these low counts is not clear but this may be attributed to genetic, 
environmental or dietary factors ( Shaper and Lewis, 1971 ; Ezeilo,1974). 
 
A limitation of this study is that it did not include a longitudinal study tracking changes in individual women throughout 
pregnancy which would have provided a comprehensive understanding of immunological changes in pregnancy (Gomo et 
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al., 2003). Secondly, it is worth mentioning that CD4+ and CD8 have been observed to be stable when they are presented 
as total counts than absolute counts. 
 
In conclusion, pregnancy significantly increased the mean values of WBC count but significantly decreased CD4+ cell 
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